Testing the Effectiveness of Henna on Managing PPE
Status:
Completed
Trial end date:
2018-06-15
Target enrollment:
Participant gender:
Summary
The palmar-plantar erythrodysesthesia (PPE) is the only clinical adverse event that commonly
occurs with capecitabine and/or pegylated liposomal doxorubicin treatment and it warrants
special attention because it is the most common dose-limiting toxicity. this study is
designed to test the effectiveness of a henna treatment protocol in the management of
capecitabine and/or pegylated liposomal doxorubicin induced palmar-plantar
erythrodysesthesia.